Literaturverzeichnis

Aspekte der zahnärztlichen Behandlung von Patienten mit Malignomen

Priv.-Doz. Dr. med. Dr. med. dent. Matthias Folwaczny
Abu-Id MH, Acil Y, Gottschalk J, Kreusch T. Bisphosphonatassoziierte Osteonekrose des Kiefers. Mund Kiefer Gesichtschir 10: 73-81 (2006).

American Academy of Periodontology (AAP). Periodontal considerations in the management of the cancer patient. J Periodontol 68: 791-801 (1997).

Anneroth G, Holm LE, Karlsson G. The effect of radiation on teeth. A clinical, histologic and microradiographic study. Int J Oral Surg 14: 269-74 (1985).

Barasch A, Coke JM. Cancer therapeutics: an update on its effects on oral health. Periodontol 2000 44: 44-54 (2007).

Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer. 8: 33-9 (2000).

Berenson JR, Hillner BE, Kyle RA, Anderson K, Lipton A, Yee GC, Biermann JS; American Society of Clinical Oncology Bisphosphonates Expert Panel. American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma. J Clin Oncol 20: 3719-36 (2002).

Buentzel J, Micke O, Adamietz IA, Monnier A, Glatzel M, de Vries A. Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: a randomized placebo-controlled phase III study. Int J Radiat Oncol Biol Phys 64: 684-91 (2006).

Carter DL, Hebert ME, Smink K, Leopold KA, Clough RL, Brizel DM. Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers. Head Neck 21: 760-6 (1999).

Cascinu S, Fedeli A, Fedeli SL, Catalano G. Oral cooling (cryotherapy), an effective treatment for the prevention of 5-fluorouracil-induced stomatitis. Eur J Cancer B Oral Oncol 30B: 234-6 (1994).

Castagna L, Benhamou E, Pedraza E, Luboinski M, Forni M, Brandes I, Pico JL, Dietrich PY. Prevention of mucositis in bone marrow transplantation: a double blind randomised controlled trial of sucralfate. Ann Oncol 12: 953-5 (2001).

Chambers MS, Garden AS, Kies MS, Martin JW. Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck 26: 796-807 (2004).

Chambers MS, Mellberg JR, Keene HJ, Bouwsma OJ, Garden AS, Sipos T, Fleming TJ. Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: Fluorides. Oral Oncol. 42: 934-45 (2006).

Chang DT, Sandow PR, Morris CG, Hollander R, Scarborough L, Amdur RJ, Mendenhall WM. Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Head Neck 29: 528-36 (2007).

Cheng KK, Chang AM. Palliation of oral mucositis symptoms in pediatric patients treated with cancer chemotherapy. Cancer Nurs 26: 476-84 (2003).

Cowman RA, Baron SS, Glassman AH, Davis ME, Strosberg AM. Changes in protein composition of saliva from radiation induced xerostomia patients and its effect on growth of oral streptococci. J Dent Res 62, 336 (1983).

Crawford J, Tomita DK, Mazanet R, Glaspy J, Ozer H. Reduction of oral mucositis by filgrastim (r-metHuG-CSF) in patients receiving chemotherapy. Cytokines Cell Mol Ther 5: 187-93 (1999).

Curtis RE, Rowlings PA, Deeg HJ, Shriner DA, Socie G, Travis LB, Horowitz MM, Witherspoon RP, Hoover RN, Sobocinski KA, Fraumeni JF Jr, Boice JD Jr. Solid cancers after bone marrow transplantation. N Engl J Med 336: 897-904 (1997).

De Castro G, Federico MH. Evaluation, prevention and management of radiotherapy-induced xerostomia in head and neck cancer patients. Curr Opin Oncol 18: 266-270 (2006).

DePaola LG, Peterson DE, Overholser CD Jr, Suzuki JB, Minah GE, Williams LT, Stansbury DM, Niehaus CS. Dental care for patients receiving chemotherapy. J Am Dent Assoc 112: 198-203 (1986).

Donnelly JP, Dompeling EC, Meis JF, de Pauw BE. Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis. Clin Infect Dis 20: 469-70 (1995).

Durie BG, Katz M, Crowley J. Osteonecrosis of the jaw and bisphosphonates. N Engl J Med 353: 99-102 (2005).

Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50: 695-704 (2001).

El-Sayed S, Nabid A, Shelley W, Hay J, Balogh J, Gelinas M, MacKenzie R, Read N, Berthelet E, Lau H, Epstein J, Delvecchio P, Ganguly PK, Wong F, Burns P, Tu D, Pater J.Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. J Clin Oncol 20: 3956-63 (2002).

Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98: 1531-9 (2003).

Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore P. Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg 10: 48-54 (1987a).

Epstein JB, Wong FL, Stevenson-Moore P. Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg 45: 104-10 (1987b).

Farrugia MC, Summerlin DJ, Krowiak E, Huntley T, Freeman S, Borrowdale R, Tomich C. Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Laryngoscope 116: 115-20 (2006).

Ferguson MM, Stephen KW, Dagg JH, Hunter IP. The presentation and management of oral lesions in leukaemia. J Dent 6: 201-6 (1978).

Filicko J, Lazarus HM, Flomenberg N. Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment. Bone Marrow Transplant. 31: 1-10 (2003).

Folwaczny M, Hickel R. Aspekte der zahnärztlichen Betreuung immunnsupprimierter Patienten. 1. Solide Tumoren und Strahlentherapie. Dtsch Zahnärztl Z 56: 285-297 (2001).

Folwaczny M, Hickel R. Orale Infektionen bei Patienten mit Immunsuppression. Dtsch Zahnärztl Z 57: 455-61 (2002).

Forrest DL, Nevill TJ, Naiman SC, Le A, Brockington DA, Barnett MJ, Lavoie JC, Nantel SH, Song KW, Shepherd JD, Sutherland HJ, Toze CL, Davis JH, Hogge DE. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis. Bone Marrow Transplant 32: 915-23 (2003).

Fujita M, Tanimoto K, Wada T. Early radiographic changes in radiation bone injury. Oral Surg Oral Med Oral Pathol 61: 641-4 (1986).

Garfunkel AA. Oral mucositis - the search for a solution. N Engl J Med 351: 2649-51 (2004).

Gernhardt CR, Kielbassa AM, Hahn P, Schaller HG. Tensile bond strengths of four different dentin adhesives on irradiated and non-irradiated human dentin in vitro. J Oral Rehabil 28: 814-20 (2001).

Gernhardt CR, Koravu T, Gerlach R, Schaller HG. The influence of dentin adhesives on the demineralization of irradiated and non-irradiated human root dentin. Oper Dent 29: 454-61 (2004).

Gotthard F. Über Zahnschäden nach Röntgenstrahlungen. Verh Dtsch Röntgen Ges 13: 139-42 (1922).

Grötz KA, al-Nawas B, Piepkorn B, Reichert TE, Duschner H, Wagner W. Mikromorphologische Kieferveränderungen nach Bestrahlung. Mund Kiefer Gesichtschir 3: 140-5 (1999).

Grötz KA, Diwo T, Henrich G, Wagner W. Wundheilungsstörungen nach chirurgischer Zahnsanierung prae und post radiationem bei malignen Kopf-Hals-Tumoren. Dtsch zahnärztl Z 49: 1036 (1994).

Grötz KA, Duschner H, Kutzner J, Thelen M, Wagner W. Histotomographische Untersuchungen zur Frage direkt radiogener Schmelzveränderungen. Mund Kiefer Gesichtschir 2: 85-90 (1998).

Grötz KA, Duschner H, Wagner W. [Konfokale Laser-Scanning-Mikroskopie (CLSM): Histo-Tomographie veränderter Zahnhartgewebe bei pathologischer Mundhöhlenökologie. Mund Kiefer Gesichtschir 1: 39-43 (1997).

Gutta R, Louis PJ. Bisphosphonates and osteonecrosis of the jaws: science and rationale. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 104: 186-93 (2007).

Hancock PJ, Epstein JB, Sadler GR. Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc 69: 585-90 (2003).

Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63: 682-9 (2005).

Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA, Cauley JA, Blumenstein BA, Albain KS, Lipton A, Brown S; American Society of Clinical Oncology. American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer. J Clin Oncol 21: 4042-57 (2003).

Jansma J, Vissink A, Gravenmade EJ, Visch LL, Fidler V, Retief DH. In vivo study on the prevention of postradiation caries. Caries Res 23: 172-8 (1989).

Keene HJ, Daly T, Brown LR, Dreizen S, Drane JB, Horton IM, Handler SF, Perkins DH. Dental caries and Streptococcus mutans prevalence in cancer patients with irradiation-induced xerostomia: 1-13 years after radiotherapy. Caries Res 15: 416-27 (1981).

Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Luckel H. Radiation-related damage to dentition. Lancet Oncol 7: 326-35 (2006).

Kielbassa AM, Rowbotham F, Hellwig E, Schade-Brittinger C. Der Einfluss der Mundhygiene auf die Entstehung der initialen Karies an tumortherapeutisch bestrahltem Schmelz. Dtsch zahnärztl Z 52, 735 (1997).

Knowles JC, Chalian VA, Shidinia H. Pulp innervation after radiation therapy. J Prosteht Dent 56: 708-11 (1986).

Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 62: 1187-94 (2005).

Leung WK, Jin LJ, Samaranayake LP, Chiu GK. Subgingival microbiota of shallow periodontal pockets in individuals after head and neck irradiation. Oral Microbiol Immunol 13: 1-10 (1998).

Lockhart PB, Durack DT. Oral microflora as a cause of endocarditis and other distant site infections. Infect Dis Clin North Am 13: 833-50 (1999).

Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, et al. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol 9: 449-52 (1991).

Markitziu A, Heling I. Endodontic treatment of patients who have undergone irradiation of the head and neck. A longitudinal follow-up of eleven endodontically treated teeth. Oral Surg Oral Med Oral Pathol 52: 294-8 (1981).

Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567-75 (2005).

Marx RE. Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 41: 283-8 (1983).

McGuire DB, Correa ME, Johnson J, Wienandts P. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Support Care Cancer 14: 541-7 (2006).

Okuno SH, Foote RL, Loprinzi CL, Gulavita S, Sloan JA, Earle J, Novotny PJ, Burk M, Frank AR. A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer 79: 2193-9 (1997).

Otmani N. Oral and maxillofacial side effects of radiation therapy on children. J Can Dent Assoc 73: 257-61 (2007).

Peterson DE. Oral toxicity of chemotherapeutic agents. Semin Oncol 19: 478-91 (1992).

Pioch T, Mayer T. Mikroskopische Untersuchungen an Frakturflächen von Zähnen mit "radiogener" Karies. Stomatologie 97: 19-25 (1997).

Raber-Durlacher JE, Epstein JB, Raber J, van Dissel JT, van Winkelhoff AJ, Guiot HF, van der Velden U. Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer 10: 466-73 (2002).

Rades D, Fehlauer F, Bajrovic A, Mahlmann B, Richter E, Alberti W. Serious adverse effects of amifostine during radiotherapy in head and neck cancer patients. Radiother Oncol 70: 261-4 (2004).

Reddy SP, Leman CR, Marks JE, Emami B. Parotid-sparing irradiation for cancer of the oral cavity: maintenance of oral nutrition and body weight by preserving parotid function. Am J Clin Oncol 24: 341-6 (2001).

Regelink G, Vissink A, Reintsema H, Nauta JM. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence Int 29: 383-8 (1998).

Robert Koch Institut (RKI) und Gesellschaft der epidemiologischen Krebsregister in Deutschland (Hrsg.). Krebs in Deutschland - Häufigkeiten und Trends. 5. Auflage. Saarbrücken (2006).

Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl): 2026-46 (2004).

Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62: 527-34 (2004).

Saarilahti K, Kouri M, Collan J, Hamalainen T, Atula T, Joensuu H, Tenhunen M. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 74: 251-8 (2005).

Santini D, Vespasiani Gentilucci U, Vincenzi B, Picardi A, Vasaturo F, La Cesa A, Onori N, Scarpa S, Tonini G. The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol 14(: 1468-76 (2003).

Schiodt M, Hermund NU. Management of oral disease prior to radiation therapy. Support Care Cancer 10: 40-3 (2002).

Schwartz HC, Kagan AR. Osteoradionecrosis of the mandible: scientific basis for clinical staging. Am J Clin Oncol 25: 168-71 (2002).

Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol 7: 175-83 (2006).

Scully C, Sonis S, Diz PD. Oral mucositis. Oral Dis 12: 229-41 (2006).

Seikaly H, Jha N, McGaw T, Coulter L, Liu R, Oldring D. Submandibular gland transfer: a new method of preventing radiation-induced xerostomia. Laryngoscope 111: 347-52 (2001).

Seto BG, Kim M, Wolinsky L, Mito RS, Champlin R. Oral mucositis in patients undergoing bone marrow transplantation. Oral Surg Oral Med Oral Pathol 60: 493-7 (1985).

Shaw MJ, Kumar ND, Duggal M, Fiske J, Lewis DA, Kinsella T, Nisbet T. Oral management of patients following oncology treatment: literature review. Br J Oral Maxillofac Surg 38: 519-24 (2000).

Sonis ST, Peterson RL, Edwards LJ, Lucey CA, Wang L, Mason L, Login G, Ymamkawa M, Moses G, Bouchard P, Hayes LL, Bedrosian C, Dorner AJ. Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters. Oral Oncol 36: 373-81 (2000).

Sonis ST. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 34: 39-43 (1998).

Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 4: 277-84 (2004).

Spielberger R, Stiff P, Bensinger W, Gentile T, Weisdorf D, Kewalramani T, Shea T, Yanovich S, Hansen K, Noga S, McCarty J, LeMaistre CF, Sung EC, Blazar BR, Elhardt D, Chen MG, Emmanouilides C. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351: 2590-8 (2004).

Stokman MA, Spijkervet FK, Boezen HM, Schouten JP, Roodenburg JL, de Vries EG. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res 85: 690-700 (2006).

Studer G, Gratz KW, Glanzmann C. Osteoradionecrosis of the mandibula in patients treated with different fractionations. Strahlenther Onkol 180: 233-40 (2004).

Symonds RP. Treatment-induced mucositis: an old problem with new remedies. Br J Cancer 77: 1689-95 (1998).

Tänzer J, Wilde F, Liese J, Niederwieser D, Al-Ali HA. Ostenecrosis of the jaw bone in connection with the application of bisphosphonates. Onkologie 28: 210 (2005).

Thorn JJ, Hansen HS, Specht L, Bastholt L. Osteoradionecrosis of the jaws: clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg 58: 1088-93 (2000).

Toljanic JA, Saunders VW. Radiation therapy and management of the irradiated patient. J Prosthet Dent 52: 852-8 (1984).

Tong AC, Leung AC, Cheng JC, Sham J. Incidence of complicated healing and osteoradionecrosis following tooth extraction in patients receiving radiotherapy for treatment of nasopharyngeal carcinoma. Aust Dent J 44: 187-94 (1999).

Vissink A, Burlage FR, Spijkervet FK, Jansma J, Coppes RP. Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 14: 213-25 (2003a).

Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14: 199-212 (2003b).

Wasserman TH, Brizel DM, Henke M, Monnier A, Eschwege F, Sauer R, Strnad V. Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial. Int J Radiat Oncol Biol Phys 63: 985-90 (2005).

Weitzman R, Sauter N, Eriksen EF, Tarassoff PG, Lacerna LV, Dias R, Altmeyer A, Csermak-Renner K, McGrath L, Lantwicki L, Hohneker JA. Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006. Crit Rev Oncol Hematol 62: 148-52 (2007).